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Abstract: An industrial clavulanic acid (CA) overproducer Streptomyces clavuligerus strain, namely DEPA, was engineered to further
enhance its CA production. Single or multiple copies of ccaR, claR (pathway-specific activators), and cas2 (CA synthase) genes under
the control of different promoters were introduced into this strain. CA titers of the resulting recombinants were analyzed by HPLC in
a dynamic fashion and compared to the vector-only controls and a wild-type strain of S. clavuligerus while their growth was monitored
throughout fermentation. The addition of an extra copy of ccaR, under control of its own promoter or constitutive ermE* promoter
(PermE*), led to 7.6- and 2.3-fold increased volumetric levels of CA in respective recombinants, namely the AK9 and ID3 strains. Its
highly stable multicopy expression by the glpF promoter (PglpF) provided up to 25.9-fold enhanced volumetric CA titers in the respective
recombinant, IDG3. claR expression controlled with its own promoter or ermE* and glpF-mediated amplification in an industrial
strain brought about only about 1.2-fold increase in the volumetric CA titers. An extra copy of cas2 integration with PermE* into the S.
clavuligerus DEPA genome led to 3.8-fold higher volumetric CA production by GV61. Conclusively, multicopy expression of ccaR under
PglpF can result in significantly improved industrial high-titer CA producers.
Key words: Clavulanic acid, industrial Streptomyces clavuligerus, strain improvement, promoters, ccaR overexpression

1. Introduction
Clavulanic acid (CA) is one of the most important
secondary metabolites naturally produced by Streptomyces
clavuligerus. It is a member of very powerful class of
β-lactamase inhibitors with very weak antibiotic activity
(minimal inhibitory concentration around 25–125 µg/
mL) (Baggaley et al., 1997). CA exerts its effect on
penicillin- and cephalosporin-resistant bacteria in such
a way that it irreversibly binds to the serine hydroxyl
group in the catalytic sites of β-lactamases and leads
to the formation of a highly stable and inactive enzyme
(Foulstone and Reading, 1982; Baggaley et al., 1997). Its
industrial production is based on large-scale S. clavuligerus
fermentations, as its chemical synthesis in such volumes is
not practical (Bentley et al., 1977; Ferguson et al., 2016).
Three distinct gene clusters, namely CA and 5S clavams
located in the S. clavuligerus genome and the paralog
gene cluster found in the megaplasmid, are involved in
* Correspondence: aslihan.kizildogan@omu.edu.tr
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CA and clavam biosynthesis (Medema et al., 2010). In
addition, cephamycin C and CA clusters are consecutively
positioned on the chromosome as a 60-kb β-lactam
supercluster (Ward and Hodgson, 1993). Characterization
of the CA gene cluster is still an ongoing process. However,
essential genes such as cas2 (clavaminate synthase, CAS, a
rate-limiting enzyme) have already been identified (Song
et al., 2009). CA regulation is accomplished by pleiotropic
and pathway-specific regulators at the molecular level.
The best known pathway-specific regulators of CA
biosynthesis are CcaR and ClaR, which are transcriptional
activators encoded by ccaR (located in the cephamycin C
gene cluster), and pathway-specific activators encoded by
claR, respectively (Liras et al., 2008).
Media optimization, genetic and metabolic
engineering, and synthetic biology approaches have
been commonly used for obtaining high-titer industrial
metabolites, especially β-lactams (Olano et al., 2008;
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Nielsen et al., 2009; Baltz, 2011; Özcengiz and Demain,
2013). The use of random mutagenesis and screening
strategies provided an industrial S. clavuligerus strain that
produces 100-fold higher CA production than its wildtype counterpart (Medema et al., 2011a). However, such
classical techniques are tedious and time-consuming, and
rational technologies are more preferred by researchers.
Moreover, the combination of classical strain isolation
techniques with modern strain engineering strategies
results in multiple complex phenotypes (Patnaik, 2008).
In general, the amount of secondary metabolite produced
by standard strains is much lower than what is required
for industrial-scale production; therefore development
of a super-producer strain by manipulating high-titer
industrial ones is a very rational option (Nielsen et al.,
2009; Pickens et al., 2011). In the literature, there is only
one relevant report in which a double disruption of the lat
and cvm genes (lat::apr-cvm::apr) involved in cephamycin
C and clavam biosynthesis, respectively, resulted in a
10% increment in CA yield in commercial S. clavuligerus
(Paradkar et al., 2001).
Integrative and/or multicopy expressions of cas2,
claR, and ccaR under the control of different promoters
in wild-type S. clavuligerus have resulted in enhanced CA
production (Pérez-Llarena et al., 1997; Pérez-Redondo et
al., 1998; Hung et al., 2007; Baltz, 2011; Guo et al., 2013).
Indeed, the use of previously reported gene manipulations
on industrial strains obtained from random mutation
strategies might yield more productive strains (Paradkar,
2013). Thus, in the present study, we aimed at enhancing
CA yields of the industrial S. clavuligerus strain DEPA
to obtain a versatile CA super-producer with the use of
different vector systems and promoters by (i) insertion
of ccaR expressed from its own promoter or ermE*
constitutive promoter (PermE*) by the use of the pSET152
integration vector (Wilkinson et al., 2002) and from a
strong glycerol inducible glpF promoter (PglpF) in the pSPG
multicopy plasmid (Kurt et al., 2013), (ii) integrative/
multicopy expression of claR under the control of its
own promoter and PermE* and PglpF, respectively, and (iii)
cas2 gene expression with the ermE* promoter. To our
knowledge, this study reports for the first time an absolute
quantification of high-titer CA production via HPLC
in recombinant industrial bacteria constructed using a
rational approach.
2. Materials and methods
2.1. Bacterial strains, plasmids, and culture conditions
The microorganisms and plasmid vectors used in the
study are listed in Table 1. Escherichia coli strains were
grown in either Luria broth (LB) (Merck) or on agar plates
at 37 °C, supplemented with the appropriate amount
of antibiotics when necessary (ampicillin 100 µg/mL,

kanamycin 25 µg/mL, chloramphenicol 25 µg/mL; all
purchased from Sigma). DNA manipulations were carried
out in E. coli DH5α and then E. coli ET12567/pUZ8002
to avoid the restriction barrier of S. clavuligerus before
conjugation. MS agar (Hobbs et al., 1989) was used to
grow exconjugants after conjugation. S. clavuligerus DEPA
was grown in vegetation medium [per liter: soy flour, 20
g; dextrin, 10 g; KH2PO4, 0.6 g; glycerol trioleate (GTO),
5 mL] as preculture and in fermentation medium [per
liter: soy flour, 20 g; dextrin, 10 g; KH2PO4, 0.6 g; GTO,
5 g; MOPS, 10.5 g; oligo elements solution (per liter:
CaCl2, 10 g; MgCl2.6H2O, 10 g; FeCl3, 3 g; ZnCl2, 0.5 g;
MnSO4.H2O; 0.5 g; NaCl, 10 g), 10 mL] for CA production.
Precultures that reached an OD600 value of around 6 were
used to inoculate fermentation media in a 1/100 ratio. The
fermentation cultures were supplemented with GTO (0.8
mL/40 mL) at 96 h of incubation. Fermentations were
carried out on rotary shakers in baffled flasks at 23.5 °C.
For CA bioassay, Klebsiella pneumoniae ATCC 29665 was
grown in TSB (Oxoid) at 30 °C and 200 rpm to get an
OD600 value of 0.9–1.0.
2.2. Construction of plasmids and strains
Chromosomal DNA of S. clavuligerus DEPA was isolated
by using the salting-out procedure described by Pospiech
and Neumann (1995) and used as template DNA for PCR
cloning of the ccaR, claR, and cas2 genes. Primers designed
for PCR amplifications were synthesized by Alpha DNA
(Montreal, Canada) and are listed in Table 2. PCR reactions
were prepared as follows: template DNA (50 ng), 1 µL; 10C
PCR buffer, 2.5 µL; 10 mM dNTP, 1 µL; DMSO, 1 µL; each
forward and reverse primer (10 µM), 1.25 µL; Taq DNA
polymerase (Thermo Fisher Scientific, 5 U/µL), 0.5 µL;
MgCl2 (25 mM), 2 µL; dH2O, 14.5 µL. The PCR conditions
were started with an initial denaturation step (10 min
at 94 °C), followed by 35 cycles of amplification (45 s at
95 °C for denaturation, 45 s at Tm-5 °C for annealing, 1
min/1 kb at 72 °C for extension), and ended with a final
extension step of 72 °C for 10 min. Enzymes (all 10 U/µL
in concentration except for Taq DNA polymerase) used in
cloning experiments were from Thermo Fisher Scientific
(Petaluma, CA, USA).
2.2.1. The sources/properties of plasmids and related
promoters
pSPG (Supplementary Figure 1a) is a pIJ699-derived
replicable vector with a copy number ranging from 40
to 300 per cell (Kieser and Melton, 1988). PglpF in the
pSPG vector is a glycerol-inducible promoter found
in a glycerol utilization pathway in S. clavuligerus that
coordinates GlyR-dependent regulation (Baños et al.,
2009). In addition, pSET152 (Supplementary Figure
1b) is an integrative vector that is unable to replicate in
Streptomyces, but with the presence of the fC31 (phiC31)
attP-int locus in its sequence, it is inserted into the phiC31
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Table 1. Bacterial strains and plasmids used in this study.
Strain/plasmid

Description

Source or reference

Industrial S. clavuligerus DEPA

Clavulanic acid overproducer

DEPA Pharmaceuticals İzmit, Turkey

S. clavuligerus pSET152/VC

pSET152 without gene insert integrated into S. clavuligerus DEPA

This study

S. clavuligerus pSET152ErmE*/VC

pSET152ErmE* without gene insert integrated into S. clavuligerus
DEPA

This study

S. clavuligerus pSPG/VC

pSPG without gene insert propagated in S. clavuligerus DEPA

This study

S. clavuligerus AK9

Recombinant industrial S. clavuligerus with ccaR inserted in
pSETccaR integration vector

This study

S. clavuligerus ID3

Recombinant industrial S. clavuligerus with ccaR inserted in pEccaR
integration vector

This study

S. clavuligerus IDG3

Recombinant industrial S. clavuligerus with ccaR inserted in
pGlpFccaR multicopy expression vector

This study

S. clavuligerus MA28

Recombinant industrial S. clavuligerus with claR inserted in pEclaR
integration vector

This study

S. clavuligerus MAG2

Recombinant industrial S. clavuligerus with claR inserted in
pGlpFclaR multicopy expression vector

This study

S. clavuligerus GV61

Recombinant industrial S. clavuligerus with cas2 inserted in pEcas2
integration vector

This study

Klebsiella pneumoniae ATCC 29665

Clavulanic acid indicator strain

Professor P Liras, INBIOTEC, Leon,
Spain

E. coli DH5α

F` ϕdlacZM15 (lacZYA argF), U169, supE44λ-, thi-1, gyrA, recA1,
relA1, endA1, hsdR17

E. coli Genetic Stock Center

E. coli ET12567/pUZ8002

F- dam 13::Tn9 dcm-6 hsdM hsdR, lacYI

K Chater, John Innes Centre,
Norwich, UK

Strains

Plasmids
pGEM-T Easy

AmpR, lacZ’

Promega

pBluescript II KS (+)

Phagemid, AmpR, lacZ’

Stratagene

pSPG

Ampicillin- and apramycin-resistant (AmpR, AprR), Streptomyces-E.
coli multicopy vector containing the promoter of the glpF gene, and
aac(3)IV-oriT

P Liras, INBIOTEC, León, Spain

pSET152

lacZ, reppuc, attФC31, oriT

Bierman et al. (1992)

pSET152ErmE*

lacZ, reppuc, attФC31, oriT, ermE*

Combinature Biopharm AG,
Wilkinson et al. (2002)

pGccaR

pGEM-T Easy with S. clavuligerus ccaR gene at its EcoRI site

This study

pGpccaR

pGEM-T Easy with S. clavuligerus pccaR gene at its EcoRI site

This study

pEccaR

pSET152ErmE* with S. clavuligerus ccaR gene at its EcoRI site

This study

pSETccaR

pccaR containing pSET152 at its EcoRI site

This study

pGlpFccaR

pSPG with S. clavuligerus ccaR gene at its NdeI-SpeI recognition sites

This study

pGclaREB

pGEM-T Easy with S. clavuligerus claR gene including EcoRI-BamHI
This study
sites

pGclaRNS

pGEM-T Easy with S. clavuligerus claR gene including NdeI-SpeI
recognition sites

This study

pEclaR

pSET152ErmE* with S. clavuligerus claR gene at its EcoRI-BamHI
recognition site

This study

pGlpFclaR

pSPG with S. clavuligerus claR gene at its NdeI-SpeI recognition site

This study

pGcas2

pGEM-T Easy with S. clavuligerus cas2 gene at its EcoRI site

This study

pBKScas2

pBluescriptII KS (+) with S. clavuligerus cas2 gene at its EcoRI site

This study

pEcas2

pSET152ErmE* with S. clavuligerus cas2 gene at its XbaI site

This study
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Table 2. Primers used in this study.
Name

5¢_Primer sequence_3¢

Description

ccaR

FP : catatgaacacctggaatgatgtg
RP(ii): tccccgccgttgtgagaaga

PCR amplification of ccaR

cas2

FP: tctagaaggagacatcgtgtcatgg
RP: aagcttatgagccgggctcagc

PCR amplification of cas2

pccaR

FP: ttcccacagccttcccacccacccgtcccgactcgc
RP: tccccgccgttgtgagaaga

PCR amplification of ccaR with its own promoter

claR1

FP: gaattcgccgatgcgatctgtcttta
RP: ggatccgccccgggaccgtatgtc

PCR amplification of claR for pSET152ErmE* cloning

claR2

FP: catatggccgatgcgatctgtcttta
RP: actagtgccccgggaccgtatgtc

PCR amplification of claR for pSPG cloning

pSETF

FP: tagtcctgtcgggtttcgccac

pSET152 FP

To confirm insertion of pccaR in pSET152 and
ccaR, cas2 or claR in pSET152ErmE*

pSPGR

RP: tgcctttgctcggttgatcc

pSPG FP

To confirm insertion of ccaR/claR in pSPG

(i)

: Forward primer, (ii): reverse primer.

(i)

attachment site (attP) in the Streptomyces chromosome
as a single copy in theory (Medema et al., 2011b). PermE*
is the upmutated strong constitutive promoter of the
erythromycin resistance gene used for both homologous
and heterologous gene expression in Streptomyces
(Wilkinson et al., 2002). It is located in the pSET152ErmE*
vector (Supplementary Figure 1c).
2.2.2. Construction of pSETccaR, pEccaR, and pGlpFccaR
ccaR was subcloned to the pGEM-T Easy vector (Promega,
Madison, WI, USA) either as a fragment of 875 bp
(promoterless gene, ccaR) to yield pGccaR or as a 1108bp DNA fragment carrying ccaR with its own promoter
(pccaR) to yield pGpccaR. Next, ccaR was cloned to (i)
a pSET152 integration vector together with its native
promoter or ahead of the ermE* constitutive promoter for
insertion of its extra copy into the chromosome and (ii)
a pSPG expression vector carrying PglpF, a strong glycerolinducible promoter, for its multicopy expression in the
cell. Then ccaR with its own promoter was released from
pGpccaR by EcoRI digestion and cloned to pSET152 at the
EcoRI site generating pSETccaR (Supplementary Figure
1d). Meanwhile, EcoRI-digested promoterless ccaR from
pGccaR was inserted into EcoRI-linearized pSET152ErmE*
and referred to as pEccaR (Supplementary Figure 1e). In
addition, NdeI-SpeI-digested ccaR released from pGccaR
was ligated to an NdeI-SpeI-digested pSPG vector to give
pGlpFccaR (Supplementary Figure 1f).
2.2.3. Construction of pEclaR and pGlpFclaR
Two different sets of primers with EcoRI-BamHI and
NdeI-SpeI recognition sites, respectively, were used to

amplify the 1426-bp claR by PCR. Both PCR fragments
were cloned to pGEM-T Easy to obtain pGclaREB (claR
in pGEM-T Easy with its EcoRI-BamHI recognition sites)
and pGclaRNS (claR in pGEM-T Easy with its NdeI-SpeI
recognition sites). Then EcoRI-BamHI-digested claR
was released from pGclaREB and was ligated to EcoRIBamHI-linearized pSET152ErmE* to generate pEclaR
(Supplementary Figure 1g), a recombinant plasmid used to
integrate an extra copy of claR into the chromosome. For
claR multicopy expression, pGclaRNS was digested with
NdeI-SpeI restriction enzymes to release the gene and this
fragment was ligated to pSPG at the NdeI-SpeI recognition
sites to give pGlpFclaR (Supplementary Figure 1h).
2.2.4. Construction of pEcas2
To yield pGcas2, cas2 was subcloned to the pGEM-T Easy
vector as a 1016-bp DNA fragment. In order to clone this
gene to the XbaI site of pSET152ErmE*, it was necessary
to add an XbaI site to its 3’ end. The cas2 gene was then
released from pGcas2 by EcoRI digestion and subcloned
to EcoRI-linearized pBlueskriptKS+ to create pBKScas2.
Finally, XbaI-digested cas2 released from pBKScas2
was inserted to pSET152ErmE* to generate pEcas2
(Supplementary Figure 1i).
Constructions were verified by restriction digestion,
PCR, or sequencing. The plasmids (pSPG, pSET152, and
pSET152ErmE*) and the recombinant ones (pSETccaR,
pEccaR, pGlpFccaR, pEclaR, pGlpFclaR, and pEcas2)
were propagated in E. coli DH5a cells. Thereafter, they
were introduced by transformation into the methylationdeficient E. coli ET12567/pUZ8002 strains in order to
obtain nonmethylated DNA.
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2.2.5. Intergeneric conjugation between Streptomyces
and E. coli
The conjugation procedure between recombinant E. coli
ET12567/pUZ8002 cells and the S. clavuligerus DEPA
strain was carried out as described by Flett et al. (1997).
Fresh LB was inoculated with 16-h-old E. coli ET12567/
pUZ8002 culture with the desired plasmid as a seed culture
and incubated in a rotary shaker at 37 °C and 200 rpm until
OD600 reached 0.4–0.6. The cells were washed twice with
equal volumes of LB at 3500 rpm for 10 min to remove the
antibiotics. The final pellet was resuspended in 0.1 volume
of LB. S. clavuligerus mycelia, 24 h old and grown on TSA,
were harvested using 5 mL of 20% sterilized glycerol.
The glycerol-dissolved S. clavuligerus mycelia and E. coli
suspension were mixed at equal volumes and overlaid
on MS agar. After 20 h of incubation at 30 °C, sterile
dH2O containing 0.5 mg/mL nalidixic acid and 1 mg/mL
selective agent was spread on plates in aliquots of 10 mL
and incubation continued for 4 further days. The presence
of plasmids in S. clavuligerus exconjugants was confirmed
by PCR in which a reverse primer of the cloned gene and
a primer designed from the internal part of the apramycin
sequence were used to amplify the desired regions (Table
2). The control strains (S. clavuligerus pSPG/VC, pSET152/
VC, and pSET152ErmE*/VC having vectors without any
gene inserted) were generated to determine the probable
effect in CA increments in recombinants. Approximately
200 exconjugants were obtained after conjugal transfers
and verification by PCR. These recombinant strains were
designated as follows: S. clavuligerus AK numbered 1 to 40
(S. clavuligerus DEPA strains carrying an additional copy
of ccaR by pSETccaR integration into the chromosome);
S. clavuligerus ID numbered 1 to 25 (S. clavuligerus DEPA
strains carrying an additional copy of ccaR by pEccaR
integration into the chromosome); S. clavuligerus IDG
numbered 1 to 10 (S. clavuligerus DEPA having extra
ccaR overexpressed from pGlpFccaR); S. clavuligerus MA
numbered 1 to 30 (S. clavuligerus DEPA strains carrying
an additional copy of claR as a result of pEclaR integration
into the chromosome); S. clavuligerus MAG numbered
1 to 8 (S. clavuligerus DEPA strains having extra claR
overexpressed from pGlpFclaR); and S. clavuligerus GV
numbered 1 to 80 (S. clavuligerus DEPA strains carrying
an additional copy of cas2 as a result of pEcas2 integration
into the chromosome).
2.3. Nucleotide sequencing
DNA sequencing was carried out at RefGen Biotechnology,
Inc. (Ankara, Turkey) by the chain termination method.
Deduced nucleotide sequences were compared with
the use of the BLAST search in the National Center for
Biotechnology Information database (http://www.ncbi.
nlm.nih.gov/BLAST).
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2.4. Fermentation, growth determination, and CA
bioassay
Fermentation experiments were performed by growing
three biological replicates of S. clavuligerus DEPA and its
recombinants, including their respective controls, in the
fermentation medium. All experiments were repeated
two times. Aliquots of 1 mL were taken from each flask
for DNA quantification and CA bioassay. An additional
0.5 mL of culture sample was taken from the cultures for
HPLC analysis. Growth measurement of cultures via DNA
quantification was performed according to Burton (1968).
The amounts of DNA samples were calculated according to
a standard curve drawn using the data obtained by herring
sperm and expressed as µg of DNA per mL of culture. The
agar plate diffusion method was used for CA bioassay, with
K. pneumoniae ATCC 29665 as the indicator organism
(Romero et al., 1984). Potassium clavulanate was kindly
provided by DEPA Pharmaceuticals, Turkey, and used
as the standard in the bioassay and HPLC experiments.
All exconjugant strains were tested in terms of their
CA production by bioassay. Afterwards, the selected
recombinant strains were further analyzed by HPLC to
compare their CA production capacities.
2.5. HPLC quantification of CA
Culture supernatants were 5-fold diluted with 48.7 mM
sodium acetate buffer, pH 6.0, and mixtures were filtered
through a Millipore membrane (pore diameter: 0.4 µm).
HPLC was performed by using a Varian Prostar Separations
Module and Pursuit C18 (A3000150x046, Serial No.
318437) reverse column with a flow rate of 1.0 mL/min.
The samples were eluted with a mobile phase composed of
0.1 M sodium dihydrogen phosphate buffer, pH 4.0, and
HPLC grade methanol in a 95:5 ratio. The column eluent
was monitored at 210 nm with the Varian PDA Detector
Model 330. As the CA peak of the standard sample was
obtained at minutes 3–5 of the run, 7 min was chosen as
the total run time for each injection. All injections were
performed at 21 °C and repeated two times. The related
chromatograms are given in Supplementary Figure 2.
2.6. Plasmid stability test
The stability of the pGlpFccaR plasmid (ccaR-carrying
pSPG) in S. clavuligerus IDG3 was determined by
performing a colony plating assay as described by Fong et
al. (2007), with slight modifications: (i) cultivation time
before each passage was set to 24 h and the diluted S.
clavuligerus IDG3 cells were subcultured 15 times, and (ii)
at each subculturing, the diluted cells were grown in TSA.
2.7. Statistical analysis
The HPLC data were statistically evaluated by carrying out
a one-tailed t-test to compare CA yields of the parental and
manipulated industrial S. clavuligerus strains in Minitab
Statistical Software (Minitab Inc., State College, PA, USA).
Error bars represent 95% confidence intervals.
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3. Results
As a preliminary study, the ccaR, claR, and cas2 genes were
amplified by PCR using S. clavuligerus DEPA genomic DNA
as a template and were sequenced to determine whether
they had any mutations. The nucleotide sequences of genes
were exactly the same as those found in the wild type (data
not shown). Based on these results, we conducted our
experiments to further improve CA production in the
industrial strain, which has more than 100-fold higher CA
production capacity than the wild type (data not shown).
3.1. Growth and CA production by S. clavuligerus AK9,
ID3, and IDG3 strains carrying ccaR overexpressed from
different promoters
There have been several reports indicating the strong
regulatory effect of the ccaR gene both in cephamycin C
and CA production in the wild-type S. clavuligerus (Pérez
Llarena et al., 1997; Kurt et al., 2013). Based on these data,
we primarily focused on ccaR to determine its effect on
CA production in DEPA. Therefore, we constructed three
different recombinant strains carrying an additional copy
of ccaR under the control of distinct promoters: the ccaR
promoter (PccaR) (1), strong constitutive ermE* promoter
(PermE*) (2), and strong inducible glpF (PglpF) promoter (3).
The S. clavuligerus AK9 strain with an additional copy
of ccaR expressed from its native promoter grew better than
S. clavuligerus DEPA during fermentation and exhibited a
growth pattern quite similar to that of its vector control
(Figure 1a). Therefore, S. clavuligerus AK9 provided 7.6fold higher volumetric (958.5 mg/L) CA production at
T144 compared to S. clavuligerus pSET152/VC (125 mg/L).
At the same time, this strain had a maximum specific CA
titer of 448.3 mg/g that corresponds to a 6.7-fold higher
production (specific CA titer of the vector control was 66.8
mg/g) (Figures 1b and 1c).
The growth of S. clavuligerus ID3 was better than that
of the parental strain and pSET152ErmE*/VC, especially
at T96 (Figure 1d). The expression of an extra copy of ccaR
under the control of PermE* resulted in improved CA titers
by S. clavuligerus ID3. In regard to volumetric CA titers,
1.8- to 2.3-fold increases were recorded with ID3 (582.5
and 584.83 mg/L) compared to the vector control at T120
(324 mg/L) and T144 (249 mg/L), respectively (Figure
1e). Accordingly, S. clavuligerus ID3 produced 1114.8
mg/g specific CA at T144, which corresponds to a CA
titer 1.65-fold higher than the control (DEPA strain and
S. clavuligerus pSET152ErmE*/VC produced 675 mg/g
and 552 mg/g specific CA, respectively, at this time stage)
(Figure 1f).
Among the strains compared, the best CA overproducer
was S. clavuligerus IDG3, in which ccaR (cloned in pSPG,
a free replicating multicopy plasmid) was expressed from
PglpF. Interestingly, the growth of S. clavuligerus IDG3
was slightly lower than that of the controls throughout

the fermentation (Figure 1g). This strain had the highest
increases of volumetric CA production [4575 mg/L (9.5fold) and 6690 mg/L (25.9-fold)] compared to the vector
control (482.5 mg/L and 259 mg/L) at T144 and T168,
respectively. It also produced as much as 13,137.2 mg/g
CA at T144, corresponding to a 10.5-fold increased CA level
relative to its vector control (1244.1 mg/g) (Figures 1h and
1i). Due to its high CA production capacity, the stability
of pGlpFccaR in the recombinant S. clavuligerus IDG3
was determined through a plasmid-curing experiment.
The recombinant plasmid was stable after 7 subcultures in
nonselective media at a 93% ratio (Supplementary Figure
3).
3.2. Growth and CA production by S. clavuligerus MA28
and MAG2 strains carrying claR expressed from ermE*
and glpF promoters, respectively
claR is pathway-specific regulatory gene in the CA
biosynthesis cluster. Its overexpression increases CA
biosynthesis, but this increase does not reach the levels
obtained by ccaR overexpression in the wild-type S.
clavuligerus (Pérez-Redondo et al., 1998). To investigate
its effect on the CA yield of our industrial strain, we used
ermE* and its own promoter (PclaR) to add its additional
copy into the chromosome, as well as the glpF promoter
for its multicopy expression in the cell.
The recombinant strain S. clavuligerus MA28, which
has an extra copy of the claR gene under the control of
PermE*, exhibited a slightly higher growth pattern (Figure 2a)
and did cause an increase in both volumetric and specific
CA production in comparison to the control (produced
1.2-fold more CA at T144 than the vector control). Hence,
its specific CA titer was 1.28-fold higher at T120 (Figures
2b and 2c). Integrative expression of claR (with its native
promoter) was also quantified; however, no statistically
significant increase in CA production was observed (data
not shown).
Simultaneously, multicopy expression of claR with the
control of PglpF was analyzed by HPLC. This recombination
slightly increased the growth until T72 compared to the
control (Figure 2d) and also resulted in an increased
volumetric CA yield in S. clavuligerus MAG2, providing
a 1.14-fold elevated CA level at T144 (Figures 2e and 2f).
Thus, both integrative expression of claR (with PermE*) and
its multicopy expression (with PglpF in pSPG) gave rise to
increased CA yields.
3.3. Growth and CA production by industrial S.
clavuligerus strains carrying cas2 expressed from the
ermE* promoter
cas2 encodes a biosynthetic enzyme involved in the early
steps of the CA biosynthesis pathway. Its overexpression
and its insertion together with ccaR in the wild-type
S. clavuligerus resulted in an elevated CA level (Hung
et al., 2007). Therefore, we introduced an extra copy
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Figure 1. The effect of ccaR integrative and multicopy expression under the control of different promoters on growth (DNA concentration)
(a, d, g), volumetric (b, e, h), and specific (c, f, i) CA production in S. clavuligerus AK9 (■), ID3 (♦), and IDG3 (▲) with respect to the
strain DEPA (○) and vector-only controls [pSET152/VC (□): pSET152 integrated S. clavuligerus DEPA vector control, pSET152ErmE*/
VC (◊): pSET152ErmE*-integrated S. clavuligerus DEPA vector control, pSPG/VC (∆): pSPG-containing S. clavuligerus DEPA vector
control].
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Figure 2. The effect of claR integration and its multicopy expression under the control of PermE* and PglpF, respectively, on growth (a, d),
volumetric (b, e), and specific (c, f) CA production in S. clavuligerus MA28 (■) and MAG2 (▲) with respect to the strain DEPA (○) and
vector-only controls. pSET152ErmE*/VC (□): pSET152ErmE*-integrated S. clavuligerus DEPA vector control, pSPG/VC (∆): pSPGcontaining S. clavuligerus DEPA vector control.
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of cas2 expressed from ermE* into the chromosome of
S. clavuligerus DEPA to see its effect on the strain’s CA
production. The constructed strain S. clavuligerus GV61
grew much more poorly in the fermentation medium
than the parental strain and its vector control (Figure
3a). However, S. clavuligerus GV61 displayed a 3.8-fold
increased volumetric (646 mg/L) and 14.4-fold increased
specific CA titer compared to the vector control (168 mg/L
and 72.7 mg/g) during fermentation (Figures 3b and 3c).
4. Discussion
CA is an industrially important secondary metabolite due
to its inhibitory action on b-lactamases. There have been
many examples of strain improvement strategies applied
to S. clavuligerus aiming at high levels of CA production.
These are grouped into three main categories: (i) to increase
precursor flow into the pathway, (ii) to increase the gene
dosage of key biosynthetic and regulatory genes, and (iii) to
eliminate competing reactions by oriented modifications,
as stated by Paradkar (2013). Multicopy or integrative
expression of biosynthetic/regulatory genes has generally
been the preferred strategy. For instance, multicopy and
integrative expression of the ceas2, bls2, cas2, and pah2
genes in the CA pathway together in the wild-type S.
clavuligerus increased CA yields by about 5.1- and 8.7-fold,
respectively (Jnawali et al., 2010b). cas2 overexpression, or
insertion of its extra copy into the wild-type S. clavuligerus
chromosome, resulted in an up to 5-fold increase in CA
titers. Furthermore, dual expression of the ccaR and cas2
genes via chromosomal integration induced a 23.8-fold
increase in CA yield (Hung et al., 2007). Amplification of
ccaR or claR regulatory genes yielded 3-times higher CA

level in the wild-type S. clavuligerus (Pérez-Llarena et al.,
1997; Pérez-Redondo et al., 1998). Increased dosage of
the pleiotropic regulator AdpA enhanced CA production
by almost 2-fold (López-García et al., 2010). In another
approach, inactivation of the lat gene in the cephamycin
C biosynthesis pathway in a commercial S. clavuligerus
strain resulted in a 2.5-fold increase in CA production
(Paradkar et al., 2001). On the other hand, deletion of the
glyceraldehyde 3-phosphate dehydrogenase (gap1) gene
in S. clavuligerus channeled G-3-P flux, a limiting factor
in CA biosynthesis, to the CA pathway rather than to
the glycolytic one and resulted in a 2-fold enhancement
in CA production (Li and Townsend, 2006). Moreover,
overexpression and chromosomal integration of both ccaR
and claR in a gap1-deleted mutant further improved CA
yields by 2.6-fold and 5.9-fold, respectively (Jnawali et
al., 2010a). In a study by Guo et al. (2013), recombinant
S. clavuligerus with extra ccaR under the control of the
glycerol promoter in pSET152 provided 3.19-fold more
CA production than recombinants with ccaR integration
with its native promoter in pSET152.
CcaR regulates CA production in both direct and
indirect ways. Directly, it regulates the expression of the
early genes of the CA biosynthesis pathway, ceaS2-bls-pahcas2; indirectly, it controls the late genes’ expression in the
CA cluster by regulating claR expression. In the absence of
ccaR, claR expression significantly decreased as no CcaR
binding to PclaR occurred. In the study by Álvarez-Álvarez
et al. (2014), microarray analysis revealed that the genes
responsible for arginine biosynthesis and genes for glycerol
utilization, which are precursors for CA biosynthesis
(arginine and a C3 compound derived from glycerol),

Figure 3. The effect of cas2 integration under the control of PermE* on growth (a), volumetric (b), and specific (c) CA production in S.
clavuligerus GV61 (■) with respect to the strain DEPA (DEPA) (○) and vector-only control (pSET152ErmE*/VC) (□).
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were downregulated in the ccaR-mutant compared to the
wild-type S. clavuligerus. In addition, CcaR binding to
the promoter of ceaS2 positively affected cas2 expression
(Santamarta et al., 2011; Paradkar, 2013). Medema et al.
(2011a) conducted a genome-wide gene expression analysis
of a randomly mutated industrial strain of S. clavuligerus
compared to the wild type and showed that the expression
of cas2, claR, and ccaR increased by 5.47-fold, 2.23-fold,
and 5.6-fold, respectively, in the industrial one.
In the present study, we preferred to overexpress
a key biosynthetic gene (cas2) and two regulatory
genes (ccaR and claR) separately under the control of
different promoters in S. clavuligerus DEPA to construct
recombinant high-titer CA-producers. We did not use the
multiple gene expression strategy to avoid possible side
effects on metabolic titer improvement (Rodriguez et al.,
2003; Nielsen et al., 2009; Chen et al., 2010). In addition, we
did not evaluate the possible expression differences at the
mRNA level in our manipulated strains compared to the
control, as we just focused on increases in CA production
levels. According to our results, overexpression of cas2
via chromosomal integration increased CA production
3.8-fold in volumetric and 14.4-fold in specific titer.
Amplification of claR in our industrial strain improved CA
production at a maximum rate of 1.3-fold. Furthermore,
ccaR overexpression was found to be the most effective
manipulation applied for the titer improvement in
the DEPA strain, as its chromosomal integration and
multicopy expression under PermE* and PglpF resulted in
7.6- and 25.9-fold increases in volumetric production in
strains AK9 and IDG3, respectively. To our knowledge,
the highest CA production in S. clavuligerus was reported
in the study of Jiang et al. (2004), being as much as 3000
mg/L CA titer through the optimization of fermentation
media (Demain and Dana, 2007). On the other hand, by
increasing the gene dosage of key CA biosynthetic and/or
regulatory genes, a maximum of 23-fold CA production
by S. clavuligerus was also reported (Hung et al., 2007).
Accordingly, by introducing ccaR under the control PglpF
into S. clavuligerus DEPA, our resulting recombinant
S. clavuligerus IDG3 was able to produce 6690 mg/L

CA, a much higher CA titer than ever reported before.
Thus, although IDG3 harbors a recombinant multicopy
plasmid, it can be used as an effective strain for the
industrial fermentation of CA, because at the end of seven
subcultures the recombinant expression plasmid was still
93% stable in nonselective media.
Advances in systems biological tools, such as next
generation sequencing and “-omics” technologies, have
led to more efficient ways to engineer microorganisms for
secondary metabolite titer improvement (Bro and Nielsen,
2004; Bekker et al., 2014). Furthermore, the integration of
genetic/metabolic engineering with systems biological tools
provides invaluable contributions to increase secondary
metabolite production (Hwang et al., 2014). Thus, genomewide expression profiling or comparative proteomics
analysis can be adopted for a better understanding of
CA overproduction in our industrial strain to provide
alternative ways of designing novel high-producer strains.
We have recently performed a comparative proteome
analysis between the wild-type S. clavuligerus and the
industrial DEPA strain (Ünsaldı et al., 2016). According to
the data obtained, the upregulation of some biosynthetic
enzymes in the CA pathway, some overexpressed stressand resistance-related proteins, several underrepresented
secondary metabolite genes, downregulation of amino
acid metabolism (especially methionine biosynthesis),
and lower expression levels in some enzymes of the
glycolytic system and S-adenosylmethionine synthetase
mainly account for the overall CA production in our
industrial strain. The findings obtained from the current
genetic engineering and proteomics study will be used to
design new strategies to further increase CA production in
industrial DEPA strains.
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Supplementary Figure 1. Maps of original vectors and recombinant plasmids used in manipulation of S. clavuligerus DEPA: (a) pSPG,
(b) pSET152, (c) pSET152ErmE*, (d) pSETccaR, (e) pEccaR, (f) pGlpFccaR, (g) pEclaR, (h) pGlpFclaR, (i) pEcas2.
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Supplementary Figure 2. HPLC chromatograms of CA belonging to potassium clavulanate standard and recombinant AK9, ID3, IDG3,
MA28, MAG2, and GV61 strains as well as to their vector controls at T144/T168 (*: Chromatogram of four-times diluted IDG3 sample at
T144, **: chromatogram of five-times diluted sample of IDG3 at T168).
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Supplementary Figure 3. Percent stability of pGlpFccaR plasmid in S. clavuligerus
IDG3 after 15 subcultures in TSA.
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